News
2h
Stockhead on MSNPrescient advances new therapies for hard-to-treat cancersClinical stage biotech Prescient Therapeutics is developing new therapies for cancers of unmet need, including cutaneous ...
June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...
CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...
Advocates for veterans are championing Assembly Bill 1103, which would fast-track the approval of academic studies on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results